Apropos to cGMP issues, Teva received an FDA warning letter regarding its manufacturing practices at its Jerusalem manufacturing facility, which was inspected in September.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.